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Role of microRNA (miRNA) has been highlighted in pathogen-host interactions recently. To identify cellular miRNAs involved
in the host response to enterovirus 71 (EV71) infection, we performed a comprehensive miRNA proﬁling in EV71-infected Hep2
cells through deep sequencing. 64 miRNAs were found whose expression levels changed for more than 2-fold in response to EV71
infection. Gene ontology analysis revealed that many of these mRNAs play roles in neurological process, immune response, and
cell death pathways, which are known to be associated with the extreme virulence of EV71. To our knowledge, this is the ﬁrst study
on host miRNAs expression alteration response to EV71 infection. Our ﬁndings supported the hypothesis that certain miRNAs
might be essential in the host-pathogen interactions.
1.Introduction
Hand, foot, and mouth disease (HFMD), a common febrile
illness in children, is usually caused by human enteroviruses.
Enterovirus 71 (EV71) and coxsackievirus A16 (CA16) are
two major causative agents of HFMD. EV71 and CA16
infections manifesting as lesions on the skin and oral
mucosa are clinically similar, but EV71 infection is more
frequently associated with serious neurological diseases such
as aseptic meningitis, encephalitis, and acute ﬂaccid paralysis
and fatalities [1–4] while the CA16-associated HFMD has
am i l d e ro u t c o m e[ 5]. More than 500,000 HFMD cases
caused by EV71 were reported nationwide, including 176
fatal cases in China since March 2008 [6]. Elucidating the
cellular events following EV71 infection will facilitate the
development of strategies to prevent and treat this virus.
However, the molecular mechanisms of the host response to
EV71 infection are not completely understood.
microRNAs (miRNAs) have emerged as key regulators
in many biological processes, from development to defense,
at almost all organismal levels through mRNA degradation
or translational repression of their targets [7, 8]. Recently,
theirrolehasbeenhighlightedinpathogen-hostinteractions.
Not only the miRNA encoded by viral genomes but host
encoded miRNAs have been found participating in host-
virus interactions. They can stimulate as well as suppress
viral infections. For example, liver-specic miR-122 is an
indispensable factor in supporting hepatitis C virus (HCV)
replication [9], whereas, miR-125b and miR-223 directly
target human immunodeﬁciency virus-1 (HIV-1) mRNA,
thereby attenuating viral gene expression in resting CD4+ T
cells [10]. It has been showed that Epstein-Barr virus (EBV)
encodes ﬁve miRNAs in its large DNA genome. These miR-
NAs can potentially regulate several genes encoding proteins
involved in apoptosis, cell proliferation, signal transduction,
transcription regulation, and immune response [11]. In
contrast, the global changes, miRNAs expression during
EV71 infection have not yet to be extensively elucidated. To
determine which cellular microRNAs play a role in the host
responsetoenterovirusinfection,inthisstudy,weperformed
acomprehensivemiRNAprolinginEV71-infectedHep2cells
through deep sequencing.2 Journal of Biomedicine and Biotechnology
2.MaterialsandMethods
2.1. Cell Culture and Virus Infection. Human epidermoid
carcinoma (Hep2) cells were grown in RPMI 1640 medium
(Invitrogen) supplemented with 10% fetal calf serum (FCS).
When the Hep2 cells were grown to 70% conﬂuence in
25cm2 ﬂasks, they were infected with EV71 at a multiplicity
of infection (m.o.i.) of 0.03 50% tissue culture infectious
doses (TCID50) and maintained after infection at 37
◦Ci n
RPMI 1640 medium with 2% FCS.
2.2. Isolation of RNA and miRNA. Hep2 cells were infected
with EV71 as described above. At 6h, 24h, 48h, 72h, and
96h post infection, total RNA or miRNA was extracted from
cells using the mirVana kit according to the manufacturer’s
protocol (Ambion). RNA was also extracted from nonin-
fected control cells at the same times. The quality and the
concentration of the RNA samples were monitored by gel
electrophoresis and absorbance at A260/280 ratio.
2.3. Library Construction, SOLiD Sequencing and Analy-
sis. The miRNA sequencing library construction followed
standard procedure of SOLiD small RNA expression kit
(Applied Biosystem). All SOLiD run parameters followed
standard Applied Biosystems protocols. Diﬀerent barcodes
were introduced to two samples in the polymerase chain
reaction of library construction, and all the samples were
sequenced in a single sequencing run.
2.4. Data Analysis. SOLiD data were ﬁrst analyzed by SOLiD
System Small RNA Analysis Pipeline Tool (RNA2MAP).
The miRBase sequences (Sanger) of human being were
downloaded from miRBase (http://www.mirbase.org/).The
number of bases to use when generating initial seeds
locations was 18 with a tolerance of 3mismatches. After
extension step, at most 6mismatches were allowed in full
length mapping.
Potential conserved target genes of diﬀerentially
expressed miRNAs were ﬁrstly predicted by targetscan
(http://www.targetscan.org/)[ 12–14]. Target genes of
some miRNAs, such as mir-1972, mir-1974, mir-1975,
mir-1979, and mir-764, could not be predicted in targetscan
database, we further predicted those miRNAs targets using
DIANA-microT v3.0 [15, 16]. In brief, each diﬀerentially
expressed miRNA was submitted to targetscan individually
and all of its targets predicted in targetscan or microT v3.0
were used for the following gene ontology (GO) analysis
(http://www.babelomics.bioinfo.cipf.es/). All targets of
induced and repressed miRNAs were submitted to FatiGO
program [17]. Functional category enrichment based on the
GO terms was evaluated on the targets of these diﬀerentially
expressed miRNAs.
2.5. Conﬁrmation of Diﬀerentially Expressed miRNAs by Real-
time Quantitative RT-PCR. To conﬁrm the expression of
miRNAs by deep sequencing approach, stem-loop quanti-
tative RT-PCR (qRT-PCR) was performed. In brief, cDNA
was synthesized from total RNA by using AMV reverse
Table 1: Number of reads of miRNAs from EV71 infected and non-
infected Hep2 cells.
Infected cells Control cells
High quality/both adapter 35,272 78,143
Exact match to known human miRNAs 2,731 8,457
Loose match to known human miRNAs 20,389 47,652
transcriptase (TaKaRa). The 20µl reactions were incubated
for 15min at 16
◦C, 30min at 42
◦C and 5min at 85
◦C,
and then held at 4◦C. Subsequently, real-time quantiﬁcation
was performed using an Applied Biosystems 7500 Sequence
Detection system (Applied Biosystems). The 20µlP C R
reactionsincluded1µlR T -PCRpr oduct,10µlP r emixE xT aq
(TaKaRa), and 1µl SYBR green (Invitrogen). The reactions
were incubated in a 96-well optical plate at 95
◦C for 10min,
followed by 40cycles of 95
◦C for 15s and 60
◦C for 1min.
All reactions were run in triplicate. After reaction, the
threshold cycle value (CT) data were determined using
default threshold settings, and the mean CT was determined
from the duplicate PCRs. Human small nuclear RNA U6
wasusedfornormalization.TheexpressionlevelsofmiRNAs
were measured in terms of CT and normalized to U6 using
2−ΔΔCT [18].
2.6. Statistical Analysis. We ﬁrstly used the Z test to deter-
mine the statistical signiﬁcance of the diﬀerences between
the two libraries [19]. This approach is to look at the
number of copies of a specic miRNA per cell as a fraction or
proportion of the total number of miRNA molecules in that
cell. The same proportion of specic tags should be present
in the miRNA library of all sequenced tags. In this test a
false discovery rate less than 5% was selected. miRNAs were
considered signiﬁcantly altered only when they fullled three
criteria: (1) mean fold change >2o r<0.5, (2) having at least
10 copies by SOLiD sequencing, and (3) Z score > 1.96 or
< −1.96.
3. Results
3.1. Replication of EV71 in Hep2 Cells. Cytopathic eﬀect
(CPE) was ﬁrst observed at 24h post infection and pro-
gressed to moderate and severe CPE at 72 and 96h,
respectively. miRNA extracted from cells after 72h infection
was used for SOLiD deep sequencing.
3.2. Deep Sequencing. A total of 411,419 and 479,414 ﬁltered
high quality reads were obtained from infected and control
cells by deep sequencing, respectively. After ﬁltrating reads
contaminated by rRNA, tRNA, snRNA, and snoRNA, 35,272
and 78,143 reads were obtained from infected and non-
infected cells, respectively. Out of these reads, 11,188 of
these high quality reads were exact matches while other
68,041 reads were loose matches to known human miRNAs
(Table 1).Loosematchesweredeﬁnedbysequencereadsthat
aligned with human miRNA consensus sequence with 1–4
mismatches. These may represent sequencing errors (whenJournal of Biomedicine and Biotechnology 3
Table 2: Upexpressed miRNAs in infected cells compared with non-infected cells.




hsa-mir-636 11 0 5.05958439 #
hsa-mir-619 305 41 23.59443534 17.31099765
hsa-mir-1302-8 387 54 26.46428291 16.67720702
hsa-mir-1302-2 1560 228 53.05155216 15.92193571
hsa-mir-1302-6,7 387 57 26.28151611 15.79945928
hsa-mir-1302-3 390 58 26.34977656 15.64741958
hsa-mir-1302-1 366 59 25.24116716 14.4356116
hsa-mir-1302-5 305 50 22.98061978 14.19501807
hsa-mir-1302-4 300 50 22.73564953 13.96231285
hsa-mir-1273 162 37 15.80907527 10.18871479
hsa-mir-1290 34 8 7.194848151 9.889971606
hsa-mir-1268 17 4 5.08718048 9.889971606
hsa-mir-1178 11 3 3.959263353 8.532524522
hsa-mir-1246 382 121 22.48247616 7.346561309
hsa-mir-1972 34 12 6.488332484 6.593314404
hsa-mir-1285-1 96 35 10.79491649 6.382771591
hsa-mir-566 13 5 3.901900612 6.05033557
hsa-mir-1226 10 4 3.376339014 5.817630356
hsa-mir-635 12 5 3.645008994 5.584925142
hsa-mir-627 16 7 4.132798028 5.318976326
hsa-mir-518c 13 6 3.647443806 5.041946309
hsa-mir-1185-2 20 10 4.373804587 4.654104285
hsa-mir-1289-1 14 7 3.659280977 4.654104285
hsa-mir-539 11 6 3.116008646 4.266262261
hsa-mir-1247 18 10 3.95066374 4.188693856
hsa-mir-764 12 7 3.147056335 3.989232244
hsa-mir-1979 330 201 16.15562506 3.820533368
hsa-mir-1272 11 7 2.873705427 3.656796224
hsa-mir-324 28 18 4.558616136 3.619858888
hsa-mir-1975 829 548 24.5078521 3.520303332
hsa-mir-744 28 19 4.414239693 3.429339999
hsa-mir-541 19 16 3.126630669 2.763374419
hsa-mir-1254 13 11 2.576283222 2.750152532
hsa-mir-421 42 38 4.379270931 2.572005
hsa-mir-1237 11 10 2.231381474 2.559757357
hsa-mir-320c-1 74 77 5.081196578 2.236387773
hsa-mir-615 16 17 2.309101549 2.190166722
hsa-mir-720 14 15 2.140061026 2.171915333
hsa-mir-140 184 208 7.299247353 2.058546126
hsa-mir-451 188 214 7.31642594 2.044326181
hsa-mir-21 3445 3992 31.35678948 2.008190038
occurring in low copy numbers), mutations, and/or RNA
editing events.
The size distribution of sequence reads showed that the
majority of miRNAs was 18–25 for both libraries (>90%),
with 22nt small RNA being the most abundant (Figure 1),
which is within the typical size range of human miRNAs.
After reads were compared with an miRBase database
(release 14.0), 569 miRNAs were detected in EV71-infected4 Journal of Biomedicine and Biotechnology
Table 3: Down-expressed miRNAs in infected cells compared with non-infected cells.




hsa-mir-584 0 10 −2.07306 0
hsa-mir-221 4 70 −4.6261 0.132974
hsa-let-7e 23 199 −6.40515 0.268956
hsa-mir-1180 5 43 −2.96815 0.270587
hsa-mir-1259 6 46 −2.91293 0.303529
hsa-mir-338 128 905 −12.4248 0.32913
hsa-mir-30a 304 2083 −18.6008 0.339618
hsa-mir-19b-1 487 2952 −20.5604 0.383901
hsa-mir-19b-2 491 2946 −20.3931 0.387842
hsa-mir-545 7 41 −2.33845 0.397302
hsa-mir-433 6 35 −2.15407 0.398923
hsa-mir-582 93 531 −8.27217 0.407563
hsa-mir-26a-1 129 735 −9.72425 0.408421
hsa-mir-26a-2 132 746 −9.73602 0.411757
hsa-mir-27b 123 677 −9.08034 0.422788
hsa-mir-452 31 158 −4.09666 0.456574
hsa-mir-1974 38 188 −4.34508 0.470362
hsa-mir-27a 280 1382 −11.8087 0.471472
hsa-mir-26b 35 172 −4.12863 0.473528
hsa-mir-30e 86 419 −6.39521 0.477629
hsa-mir-222 50 236 −4.64215 0.49302
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Figure 1: Size distribution of sequenced short RNAs.
cells while 540 miRNAs were detected in non-infected
control cells.
3.3. Aberrant miRNAs Expression in EV71-Infected Cells. On
the basis of diﬀerentially expressed miRNA, we found 64 that
miRNAs were diﬀerentially expressed between infected and
non-infected cells. More miRNAs (42 out of 64 miRNAs)
were upregulated than down-regulated during EV71 infec-
tion in Hep2 cells (Tables 2 and 3).
3.4. Conﬁrmation of Diﬀerentially Expressed miRNAs. Quan-
titative RT-PCR assays were used to conﬁrm the expression
pattern of diﬀerentially expressed miRNAs in Hep2 cells.
There was general consistency between quantitative RT-PCR
assayanddeepsequenceanalysisinfourmiRNAs(miR-1246,
miR-1237, miR-30a, and miR-222) in terms of directions of
regulationandsigniﬁcance.Speciﬁcally,therewasa1.92-fold
upregulation (7.35-fold in deep sequencing analysis) in miR-
1246, 1.58-fold upregulation (2.58-fold in deep sequencing




3.5. Gene Ontology Analysis. Targets were predicted for all
identiﬁed diﬀerentially expressed miRNA families. In total
5765 unique target genes were predicted for 64 of the
diﬀerentially expressed miRNAs (see Table S1 in Supple-
mentray Material available online at doi:115/2010/425939).
On the basis of the biological functions described by
FatiGO program (http://www.babelomics.bioinfo.cipf.es/),
these target genes can be grouped into 72 categories (S2).
The top 30 Gene Ontology terms are shown in Figure 2.T h e
majorityoftargetsfallintothecategoryofmetabolicprocess,
regulation of biological process, and cell communication
indicating intense biological change in Hep2 cells after EV71Journal of Biomedicine and Biotechnology 5
Table 4: Reverse regulatory association of up-regulated miRNAs and their predicted mRNA targets.
Up-regulated miRNA Target genes Functions Reference
hsa-mir-1289-1 Interferon regulatory factor 2 IFN response [20]
hsa-mir-140,hsa-mir-320c v-yes-1 Yamaguchi sarcoma viral
oncogene homolog 1 Oncogene [20]
hsa-mir-421 v-Ki-ras2 Kirsten rat sarcoma viral
oncogene homolog
[21]
hsa-mir-1226 Interleukin 10 receptor, beta Immune response [20]
hsa-mir-1290 Nuclear receptor coactivator 2 Transcriptional regulators [20]
hsa-mir-320c,hsa-mir-1290 Transcription factor AP-2 beta [20]





ribosomal protein S6 kinase Kinases and phosphatases [20]
hsa-mir-1289-1,hsa-mir-1272,hsa-
mir-421 Splicing factor, arginine/serine-rich 1 RNA synthesis and modiﬁcation [20]
hsa-mir-1272,hsa-mir-140,hsa-mir-
636 Neuro-oncological ventral antigen 1 Neuron speciﬁc [20]






cyclin-dependent kinase 6 cell cycle [21]
hsa-mir-619 protocadherin 9 cell adhesion [21]
hsa-mir-627 RER1 retention in endoplasmic
reticulum 1 homolog (S. cerevisiae) traﬃcking and targeting proteins [21]
hsa-mir-140 sorting nexin 2 [21]
hsa-mir-1289-1 xenotropic and polytropic retrovirus
receptor Cellular receptors [21]
hsa-mir-21
interleukin 12A (natural killer cell
stimulatory factor 1, cytotoxic




hsa-mir-1178,hsa-mir-140 transforming growth factor, alpha [21]
hsa-mir-1178 dual speciﬁcity phosphatase 6 intracellular
trasducers/eﬀector/modulators
[21]
infection. Several other groups contain genes regulating
death (255 target genes including 239 apoptosis-related
target genes), neurological process (211 target genes), and
immune response (120 target genes).
Hundreds of altered transcripts in response to EV71
infection were found in two transcriptomic studies [20, 21].
To determine whether miRNAs might be modulators of
mRNAs that were diﬀerentially expressed, we investigated
whether those diﬀerentially expressed mRNAs are enriched
for predicted targets and interrogated their inversely corre-
lated targets for functional associations. To our surprise, tar-
gets for diﬀerentially expressed miRNAs or miRNA families
in the present study account for 12.1% (19 out of 157) of
thediﬀerentiallyexpressedmRNAsinonestudy[20]whereas
they account for 22.4% (13 out of 58) of the transcripts that
were signiﬁcantly altered in another study (Tables 4 and 5)
[21].
4. Discussion
Many technologies have been developed for miRNA proﬁl-
ing, including real-time quantitative RT-PCR [22], north-
ern blotting [23, 24], and microarray analyses based on
either direct hybridization or hybridization coupled with
enzymatic extension [25, 26]. These methods have been
used successfully in a variety of studies. But they still have
some technical limitations. For example, ﬁrst two methods
were not high-throughput while microarray method needs
large amounts of starting materials. Recent progress in high-
throughput sequencing technologies allows deep sequencing
of large libraries of short RNAs [27–30]. The longest reads
are obtained by the 454 technology, which currently gives
reads of about 400 base pairs (bp). However, this technology
yields much less reads than other techniques (about 400
000 per sample) [27]. The Solexa (Illumina) and SOLiD6 Journal of Biomedicine and Biotechnology
Table 5: Reverse regulatory association of down-regulated miRNAs and their predicted mRNA targets.
Down-regulated miRNA Target genes Functions Reference
hsa-mir-27 Cytochrome P450,superfamily I
polypeptide 1 Mitochondrial function [20]
hsa-mir-26a,hsa-mir-27 BCL2-antagonist/killer 1 Apoptosis [20]
h s a - m i r - 2 6 a P r o g r a m m e dc e l ld e a t h1 0 [20]
hsa-mir-582 Amyloid beta (A4) precursor
protein
[20]





voltage-dependent, L type, alpha
1C subunit
Membrane transporters [20]
hsa-mir-433,hsa-let-7e Cathepsin C Protein degradation [20]
hsa-mir-26a,hsa-mir-545 Muscle RAS oncogene homolog Oncogene [20]
hsa-mir-19 RAB5B, member RAS oncogene
family
[20]
hsa-mir-19 neurotrophic tyrosine kinase,




hsa-mir-582,hsa-let-7e adaptor-related protein complex




hsa-mir-27 actin, alpha 2, smooth muscle,
aorta cytoskeleton/motility [21]
Primary metabolic process (GO: 0044238)
Cellular metabolic process (GO: 004237)
Macromolecule metabolic process (GO: 0043170)
Regulation of biological process (GO: 0050789)
Cell communication (GO: 0007154)
Cellular component organization and biogenesis
(GO: 0016043)
Multicellular organismal development (GO: 0007275)
Establishment of localization (GO: 0051234)
Anatomical structure development (GO: 0048856)
Cellular developmental process (GO: 0048869)
Cell cycle (GO: 0007049)
Biosynthetic process (GO: 0009058)
Protein localization (GO: 0008104)
Response to stress (GO: 0006950)
Cell proliferation (GO: 0008283)
Cell adhesion (GO: 0007155)
Death (GO: 0016265)
Neurological process (GO: 0050877)
Catabolic process (GO: 0009056)
Regulation of a molecular function (GO: 0051674)
Localization of cell (GO: 0051674)
Regulation of biological quality (GO: 0065008)
Response to external stimulus (GO: 0009605)
Immune response (GO: 0006955)
Nitrogen compound metabolic process (GO: 0006807)
Responce to chemical stimulus (GO: 0042221)
Defense response (GO: 0006952)
Response to endogenous stimulus (GO: 0009719)
Figure 2: Predicted targets gene ontology terms in the biological process category.
platform (Applied Biosystems) generates shorter reads (up
to 35bp) but yields 1–3 million reads per sample [28, 29].
The other high-throughput technique, such as massively
parallel sequencing (MPSS), gives more reads than Solexa
but the reads are even shorter, only 17bp [30]. In the
presentstudy,weusedSOLiDplatformtoexplorediﬀerential
miRNA proling of Hep2 cells response to EV71 infection. We
obtained about 0.4million reads in both samples, well below
thecapacityofSOLiD.Onepossibilityisthatweusedcellline
as infection model but not tissue. Numbers of small RNAs
were not expressed in Hep2 cells. Even now, we found that
there was general consistency between quantitative RT-PCR
assayanddeepsequenceanalysis.So,SOLiDdeepsequencing
successfully revealed miRNA proling in EV71-infected and
control Hep2 cells.
Based on a comprehensive examination of miRNA
expression from EV71-infected and non-infected control
Hep2 cells, we identiﬁed 64 miRNAs that were diﬀerentially
expressed, with most of them (65.6%) upregulated in EV71-
infected cells. The altered patterns of cellular miRNAs weJournal of Biomedicine and Biotechnology 7
observed for EV71-infected cells are similar in some respects
to changes seen for cells infected with Hepatitis C virus
(HCV) [31] but contrast with those with Epstein-Barr virus
(EBV) [32] and human cytomegalovirus (HCMV) in which
more miRNAs were dow-regulated in response to virus
infection [33]. Most of the miRNAs aﬀected by EV71 are
diﬀerent from those aﬀe c t e db yH C V ,E B V ,a n dH C M V .W e
observed miR-636 and miR-584 expressed in only infected
or non-infected cells. Though their functions during virus
infectionhavenotbeenexplored,theirpredictedtargetgenes
have been identiﬁed to be involved in virus entry, replication
and propagation. For example, reticulon 3 (RTN3), one
predicted target gene of miR-636, can bind the 2C protein
of enterovirus 71 and is required for viral replication, [34].
Poliovirus receptor-related 1 (herpesvirus entry mediator
C) (PVRL1, also known as nectin-1), another target gene
of miR-636, can serve as receptor for herpes simplex virus
and pseudorabies virus entry [35]. Abhydrolase domain
containing 2 (ABHD2), one predicted target gene of miR-
584, is essential for Hepatitis B virus propagation [36].
Thus, it will be important to investigate the mechanisms of
regulation of miRNA levels during virus infection, which
could be at the stages of transcription, maturation, and/or
degradation.
The host response to viral infection represents complex
orchestration of divergent pathways deigned to eliminate
the virus and protect the host. Viruses impact on many
aspects of the host cell’s biology and function [20]. As
seen from gene ontology analysis, the top 3 gene ontology
terms related to metabolic process which indicated EV71
infection have enormous eﬀect on Hep2 cells metabolism.
Intriguingly, neurological process, apoptosis, and immune
response related GO terms in biological process were also
enriched from the predicted targets. Considering the fact
that EV71 can cause lethal encephalitis or myocarditis, both
apoptosis and immune response contribute to EV71 patho-
genesis. Myocarditis, for example, represents an intricate
interplay between virus and patient responses, in which both
direct viral injury and immunopathologic damage caused
by innocent-bystander phenomena aﬀect the disease course
[37]. Further study of the functions of those underlying
miRNAs related to neurological process, apoptosis, and
immune response will help to elucidate the molecular
mechanisms of EV71 pathogenesis.
Our study has some limitations that will need to be
addressed in future studies. We did not assess the roles in
infection of miRNAs whose expression were altered after
infection. As microRNAs predominately function as repres-
sors of target gene expression, we indeed found numbers
of targets in an another transcriptomic research whose
expression was inversely correlated with the expression of
dysregulated miRNAs in the present study. Although all
assays were executed when cells demonstrated similar CPE,
the virus may interact with miRNA regulatory pathways
diﬀerently in diﬀerent cell types in which human neural
SF268 cells and rhabdomyosarcoma cells were used in
those studies, respectively. Even then, these ﬁndings sug-
gest that expression modiﬁcation of host miRNAs during
EV71 infection could be related to a number of cellular
physiological processes that eventually control the cell
fate.
In summary, in this study, we identiﬁed the miRNAs
involved in the host response to EV71 infection using
deep sequencing technology. Our ﬁndings provide a deeper
understanding of the mechanisms underlying EV71 infec-
tion.OncetheroleofthesemiRNAsintheregulationofhost-
EV71 interaction has been determined, it will improve the
protection and treatment strategies in enterovirus infection.
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